NEW YORK – A group of researchers at the University of California, Los Angeles Jonsson Comprehensive Cancer Center have received a $2.8 million grant from the National Cancer Institute to develop a blood test to help determine and refine the best candidates for liver transplants.
The team will use the NCI funding over the next five years to develop a tailored liquid biopsy-based assay to select and prioritize liver cancer patients who need an organ transplant.